10.7 Cranial Neuropathies & Neuro-Ophthalmology

ABIM Internal Medicine Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 0: The ABIM Exam, Blueprint & Study Strategy

0.1 Exam Format, Question Types & the 2026 Blueprint 0.2 Eligibility, Registration, Fees & Exam-Day Logistics 0.3 Scoring, the Passing Standard & Score Reports 0.4 Building a Blueprint-Weighted Study Plan

2 Chapter 1: Cardiovascular Disease (14% of Exam)

1.1 Ischemic Heart Disease & Acute Coronary Syndromes 1.2 Antithrombotic Therapy, Secondary Prevention & Mechanical Complications of MI 1.3 Atrial Fibrillation, Atrial Flutter & Stroke Prevention 1.4 Supraventricular Tachycardias, Ventricular Arrhythmias & Bradycardias 1.5 Heart Failure: Classification, Staging & Guideline-Directed Medical Therapy 1.6 Device Therapy, HFpEF & the Cardiomyopathies 1.7 Valvular Heart Disease & Endocarditis Prophylaxis 1.8 Pericardial Disease & Acute Aortic Syndromes 1.9 Hypertension: Classification, Diagnosis & Secondary Causes 1.10 Hypertensive Crises & Dyslipidemia 1.11 Adult Congenital Heart Disease & Coarctation of the Aorta 1.12 Syncope: Reflex, Orthostatic & Cardiac Causes 1.13 Cardiac Physical Examination, Murmurs & Antithrombotic Selection

3 Chapter 2: Endocrinology, Diabetes & Metabolism (9% of Exam)

2.1 Diabetes Mellitus: Diagnosis, Glycemic Targets & Pharmacotherapy 2.2 Insulin Therapy, Hyperglycemic Emergencies & Chronic Complications 2.3 Thyroid Function Testing & Hypothyroidism 2.4 Thyrotoxicosis, Thyroid Storm & Thyroid Nodules 2.5 Adrenal & Pituitary Disorders 2.6 Hypercalcemia, Hypocalcemia & Disorders of Mineral Metabolism 2.7 Osteoporosis & Paget Disease of Bone 2.8 Ovarian, Testicular & Reproductive Endocrine Disorders 2.9 Hypoglycemia, Endocrine Tumors, Polyglandular Syndromes & Severe Hypertriglyceridemia

4 Chapter 3: Gastroenterology & Hepatology (9% of Exam)

3.1 Esophageal Disease 3.2 Stomach & Duodenal Disease and Gastrointestinal Hemorrhage 3.3 Inflammatory Bowel Disease 3.4 Celiac Disease & Irritable Bowel Syndrome 3.5 Diverticular Disease & Colorectal Cancer Screening 3.6 Viral Hepatitis, Steatotic & Alcohol-Associated Liver Disease 3.7 Cirrhosis & the Complications of Portal Hypertension 3.8 Acute Pancreatitis 3.9 Chronic Pancreatitis & Biliary Tract Disease 3.10 Inherited, Autoimmune & Drug-Induced Liver Disease 3.11 Small Intestinal Disease, Ischemia & Gastrointestinal Complications of HIV

5 Chapter 4: Infectious Disease (9% of Exam)

4.1 Lower Respiratory Tract Infections & Sepsis Syndromes 4.2 Viral Respiratory Pathogens & Tuberculosis 4.3 Central Nervous System Infections 4.4 Skin, Soft Tissue, Bone & Joint Infections 4.5 Infective Endocarditis & Cardiovascular Infection 4.6 Clostridioides difficile & Catheter-Related Bloodstream Infection 4.7 HIV Diagnosis, Antiretroviral Therapy & Prevention 4.8 Opportunistic Infections & Sexually Transmitted Infections 4.9 Fever of Unknown Origin, Neutropenic Fever & Toxic Shock 4.10 Travel-Related Illness, Vector-Borne Disease & Outbreaks 4.11 Infection Prevention, Nosocomial Infection & Postexposure Prophylaxis 4.12 Rheumatic Fever, Poststreptococcal Disease, Enteric & Hepatic Infections

6 Chapter 5: Pulmonary Disease (9% of Exam)

5.1 COPD: Diagnosis, GOLD Classification & Initial Pharmacotherapy 5.2 Interventions That Reduce COPD Mortality & Exacerbation Management 5.3 Asthma: Diagnosis, Stepwise Therapy & Status Asthmaticus 5.4 Interstitial Lung Disease & Idiopathic Pulmonary Fibrosis 5.5 Sarcoidosis, Hypersensitivity Pneumonitis & Occupational Lung Disease 5.6 Pulmonary Embolism: Diagnosis, Risk Stratification & Anticoagulation 5.7 Pulmonary Hypertension & Sleep-Disordered Breathing 5.8 Acute Respiratory Distress Syndrome & Mechanical Ventilation 5.9 Pleural Disease, Empyema & Pneumothorax 5.10 Bronchiectasis, Cystic Fibrosis & Restrictive Lung Disease 5.11 Evaluation of Cough, Dyspnea, Hemoptysis & the Solitary Pulmonary Nodule

7 Chapter 6: Rheumatology & Orthopedics (9% of Exam)

6.1 Rheumatoid Arthritis: Diagnosis & Systemic Manifestations 6.2 Antirheumatic Pharmacotherapy & the Spondyloarthropathies 6.3 Gout: Pathophysiology & Acute Management 6.4 Urate-Lowering Therapy & Calcium Pyrophosphate Deposition Disease 6.5 Osteoarthritis 6.6 Systemic Lupus Erythematosus 6.7 Systemic Sclerosis, Sjogren Syndrome & Inflammatory Myopathies 6.8 The Vasculitides 6.9 Regional Musculoskeletal Syndromes, Back Pain & Sports Injuries 6.10 Other Primary Rheumatic Disorders & Mixed Connective Tissue Disease 6.11 Osteonecrosis & Metabolic Bone Disease

8 Chapter 7: Hematology (6% of Exam)

7.1 Approach to Anemia & the Microcytic Anemias 7.2 Macrocytic, Normocytic & Hemolytic Anemias 7.3 Hemoglobinopathies, Thalassemias & Paroxysmal Nocturnal Hemoglobinuria 7.4 Platelet Disorders, Thrombocytopenia & the Bleeding Patient 7.5 Coagulation Factor Disorders, Thrombophilia & Anticoagulant Reversal 7.6 Acute Leukemias, Chronic Leukemias & Myeloproliferative Neoplasms 7.7 Lymphomas & Plasma Cell Disorders 7.8 Myelodysplastic Syndrome, Myeloproliferative Neoplasms & Porphyria 7.9 Transfusion Medicine & Late Complications of Transplantation

9 Chapter 8: Medical Oncology (6% of Exam)

8.1 Breast, Lung, Colorectal & Prostate Cancer 8.2 Oncologic Emergencies 8.3 Genitourinary & Gynecologic Malignancies 8.4 Head and Neck, Bone & Soft Tissue Cancer and Cancer of Unknown Primary 8.5 Complications of Cancer & Its Treatment 8.6 Cancer Prevention, Survivorship & Psychosocial Care

10 Chapter 9: Nephrology & Urology (6% of Exam)

9.1 Acute Kidney Injury: Staging, Etiology & Urine Microscopy 9.2 Glomerular Disorders & Nephrotic Syndrome 9.3 Nephritic Syndromes, RPGN & Indications for Renal Replacement Therapy 9.4 Chronic Kidney Disease: Staging & Progression Retardation 9.5 Complications of Chronic Kidney Disease: Anemia, CKD-MBD & Acidosis 9.6 Hyponatremia, Hypernatremia & Water Balance 9.7 Potassium Disorders & Systematic Acid-Base Analysis 9.8 Renal Tubular Acidosis & Nephrolithiasis 9.9 Prostate Disorders, Urinary Incontinence & Other Urologic Conditions 9.10 Cystic Kidney Disease, Obstructive Uropathy, Tubulointerstitial Disease & Hematuria

11 Chapter 10: Neurology (4% of Exam)

10.1 Acute Ischemic Stroke: Syndromes & Reperfusion 10.2 Transient Ischemic Attack, Secondary Prevention & Hemorrhagic Stroke 10.3 Headache & Facial Pain 10.4 Seizures, Epilepsy & Movement Disorders 10.5 Multiple Sclerosis & Neuromuscular Junction Disorders 10.6 Motor Neuron Disease & Acute Peripheral Neuropathy 10.7 Cranial Neuropathies & Neuro-Ophthalmology 10.8 Peripheral Neuropathies, CNS Tumors & Other Neurologic Disorders

12 Chapter 11: Psychiatry & Behavioral Health (4% of Exam)

11.1 Major Depressive Disorder & Medical Mimics 11.2 Antidepressant Pharmacotherapy & Treatment-Resistant Depression 11.3 Bipolar Disorder, Mood Stabilizers & Lithium Toxicity 11.4 Anxiety, Stress-Related & Obsessive-Compulsive Disorders 11.5 Alcohol Use Disorder & Withdrawal 11.6 Pharmacotherapy for Alcohol & Opioid Use Disorder 11.7 Toxidromes, Psychiatric Emergencies & Suicide Risk Assessment 11.8 Psychotic, Somatic Symptom, Factitious & Personality Disorders 11.9 Eating Disorders, Sleep Disorders & Sexual Health

13 Chapter 12: Dermatology (3% of Exam)

12.1 Dermatitis, Papulosquamous & Inflammatory Dermatoses 12.2 Acne, Rosacea & Cutaneous Infections 12.3 Herpes Zoster & Autoimmune Blistering Diseases 12.4 Nodules, Tumors & Cutaneous Oncology 12.5 Dermatologic Emergencies & Severe Cutaneous Adverse Reactions 12.6 Pigment Disorders, Alopecia, Nail Disease & Photosensitivity 12.7 Vascular Dermatoses, Environmental Injury & Cutaneous Signs of Systemic Disease

14 Chapter 13: Obstetrics & Gynecology / Women's Health (3% of Exam)

13.1 Contraception, Preconception Care & Teratogenicity 13.2 Hypertensive Disorders of Pregnancy & Gestational Diabetes 13.3 Thyroid Disease & Venous Thromboembolism in Pregnancy 13.4 Menopause & Menopausal Hormone Therapy 13.5 Abnormal Uterine Bleeding, Endometrial Disease & Gynecologic Cancer Screening 13.6 Breast Disorders & Diseases of the Vulva and Vagina 13.7 Menstrual Disorders, Fibroids, Endometriosis & Early Pregnancy Complications

15 Chapter 14: Geriatric Syndromes (3% of Exam)

14.1 Comprehensive Geriatric Assessment & Frailty 14.2 Falls, Gait Assessment & Polypharmacy 14.3 Urinary Incontinence & Pressure Injuries in Older Adults 14.4 Mild Cognitive Impairment, Dementia & Its Subtypes 14.5 Delirium & the Pharmacotherapy of Cognitive Disorders 14.6 Palliative Care, Hospice & Advance Care Planning 14.7 Chronic Wounds, Nutrition, Swallowing, Constipation & Hip Fracture 14.8 Sensory Impairment, Dizziness, Elder Mistreatment & Care Settings

16 Chapter 15: Allergy & Immunology (2% of Exam)

15.1 Anaphylaxis: Recognition & Emergency Management 15.2 Urticaria & Angioedema 15.3 Drug Allergy, Desensitization & Adult Immunodeficiency 15.4 Food Allergy, Insect Venom Hypersensitivity, Serum Sickness & Contrast Reactions 15.5 Rhinitis, Conjunctivitis, Eosinophilic & Mast Cell Disorders

17 Chapter 16: Preventive Medicine, Immunization & Clinical Epidemiology

16.1 The USPSTF Framework & Evidence-Based Cancer Screening 16.2 Cardiovascular & Metabolic Screening and Primary Prevention 16.3 Adult Immunization & Vaccines in Special Populations 16.4 Clinical Epidemiology, Biostatistics & Study Design

18 Chapter 17: Miscellaneous - Ethics, Patient Safety & Quality Improvement (2% of Exam)

17.1 Principles of Bioethics & Decisional Capacity 17.2 Informed Consent, Treatment Refusal & Special Scenarios 17.3 Surrogate Decision-Making, Advance Directives & Confidentiality 17.4 Patient Safety Science, Medical Error & Diagnostic Reasoning 17.5 Quality Improvement Methods, Health Disparities & Health Equity

19 Chapter 18: Perioperative Medicine & Medical Consultation

18.1 Preoperative Cardiovascular Risk Assessment 18.2 Preoperative Pulmonary Risk & Perioperative Medication Management 18.3 Perioperative Anticoagulation, Bridging & Postoperative Complications

20 Chapter 19: Ophthalmology (1% of Exam)

19.1 The Acute Red Eye & Ophthalmic Emergencies 19.2 Painless Vision Loss & Chronic Ophthalmic Disease 19.3 Uveitis, Scleritis & Orbital Disease

21 Chapter 20: Otolaryngology & Dental Medicine (1% of Exam)

20.1 Dizziness, Vertigo & Epistaxis 20.2 Ear Disorders, Hearing Loss & Upper Respiratory Infections 20.3 Oral Cavity, Salivary Gland, Laryngeal & Taste and Smell Disorders

10.7 Cranial Neuropathies & Neuro-Ophthalmology

Key Takeaways Explain This Topic AI

Bell palsy and other facial nerve disorders, disorders of eye movement from cranial neuropathy, and vestibular neuronitis are enumerated under cranial neuropathy.

Optic nerve disorders including optic neuritis, pupillary abnormalities including anisocoria, disorders of eye movement and papilledema are enumerated under neuro-ophthalmology.

Forehead sparing indicates a central seventh nerve lesion, whereas complete hemifacial weakness indicates a peripheral lesion such as Bell palsy.

A third nerve palsy with pupillary involvement suggests a compressive lesion such as a posterior communicating artery aneurysm and requires emergent vascular imaging.

Papilledema is bilateral disc swelling from raised intracranial pressure with preserved acuity, whereas optic neuritis is typically unilateral with reduced acuity and an afferent pupillary defect.

Last updated: August 2026

1. Facial Nerve Palsy

The first question in any facial weakness is central or peripheral , and the answer is written on the forehead.

• Peripheral (lower motor neuron) Central (upper motor neuron)
• Forehead Involved — cannot raise the eyebrow or wrinkle the forehead Spared — forehead movement preserved
• Eye closure Impaired; incomplete lid closure Preserved
• Typical cause Bell palsy , Ramsay Hunt, Lyme disease, tumor Stroke , mass lesion

The forehead is spared centrally because the upper facial muscles receive bilateral cortical innervation ; the lower face does not. A patient who can raise both eyebrows but has a drooping mouth has a stroke until proven otherwise.

Bell palsy

Acute idiopathic peripheral facial palsy, probably from herpes simplex reactivation, evolving over hours to days. Associated features include hyperacusis (stapedius weakness), loss of taste on the anterior two-thirds of the tongue (chorda tympani), and reduced tearing.

Treatment: oral corticosteroids started within 72 hours improve the rate of complete recovery. Antivirals add little for mild-to-moderate disease and are considered in severe palsy. Eye protection is mandatory — artificial tears by day, lubricating ointment and taping or a shield at night — because an eye that will not close develops exposure keratopathy. Most patients recover substantially within weeks.

Features that argue against Bell palsy and require further evaluation: gradual onset over weeks , bilateral palsy, no improvement after three months, involvement of other cranial nerves, or a vesicular rash.

Alternative diagnosis Clue

Ramsay Hunt syndrome Vesicles in the ear canal or on the palate; more painful, worse prognosis; treat with antiviral plus steroid

• Lyme disease Endemic exposure; bilateral facial palsy is characteristic
• Sarcoidosis Bilateral palsy, parotid enlargement, uveitis (Heerfordt syndrome)
• Parotid tumor Slowly progressive palsy with a parotid mass
• HIV seroconversion Risk history

Bilateral facial palsy is essentially never Bell palsy — think Lyme disease, sarcoidosis, Guillain-Barre syndrome or HIV.

2. Disorders of Eye Movement

Nerve Deficit Clue

III (oculomotor) Eye down and out , ptosis , dilated pupil if pupil-involving Pupil involvement = compressive until proven otherwise

IV (trochlear) Vertical diplopia worse on downgaze and head tilt to the affected side Patients tilt the head away; trouble reading and descending stairs

VI (abducens) Impaired abduction, horizontal diplopia worse at distance Long intracranial course; a false localizing sign of raised intracranial pressure

The pupil rule in third nerve palsy is one of the highest-yield facts in neurology. Parasympathetic pupillomotor fibers run superficially in the nerve, supplied by the pial circulation, while the somatic motor fibers run centrally and are supplied by the vasa nervorum.

Compressive lesions (posterior communicating artery aneurysm, uncal herniation, tumor) squeeze the outside first and therefore involve the pupil early — often before ptosis and ophthalmoplegia are complete. This is a neurosurgical emergency requiring urgent CT or MR angiography.

Ischemic (microvascular) palsies — diabetes, hypertension — infarct the core and characteristically spare the pupil , often with periorbital pain, and resolve over weeks.

Internuclear ophthalmoplegia — impaired adduction of one eye with nystagmus of the abducting eye — localizes to the medial longitudinal fasciculus . Bilateral internuclear ophthalmoplegia in a young adult suggests multiple sclerosis ; unilateral in an older adult suggests brainstem stroke.

3. Pupillary Abnormalities and Anisocoria

The first step is to determine which pupil is abnormal , by comparing the anisocoria in light and in dark.

Anisocoria greater in bright light — the larger pupil is abnormal (it fails to constrict): third nerve palsy, pharmacologic dilation, Adie tonic pupil, traumatic mydriasis.

Anisocoria greater in darkness — the smaller pupil is abnormal (it fails to dilate): Horner syndrome , pharmacologic miosis.

Horner syndrome — ptosis, miosis and anhidrosis — reflects interruption of the oculosympathetic pathway. The exam value is in localizing it: painful Horner syndrome with neck pain suggests carotid artery dissection (an emergency); Horner syndrome with arm pain and hand weakness suggests a Pancoast tumor ; Horner syndrome with brainstem signs suggests lateral medullary (Wallenberg) infarction.

Relative afferent pupillary defect (Marcus Gunn pupil) — detected with the swinging flashlight test — indicates asymmetric optic nerve or extensive retinal disease, not a pupillomotor efferent problem. It is a hallmark of optic neuritis and of severe retinal artery occlusion.

Adie tonic pupil is a large pupil with poor light reaction but slow, sustained near response and often diminished deep tendon reflexes; it is benign. Argyll Robertson pupils are small, irregular pupils that accommodate but do not react to light, classically in neurosyphilis.

• 4. Optic Nerve Disorders
• Optic neuritis

Inflammatory demyelination of the optic nerve.

Classic presentation: a young adult, more often female, with subacute monocular vision loss over hours to days , pain with eye movement (present in the great majority and a key discriminator), impaired color vision (dyschromatopsia) disproportionate to acuity loss, a central scotoma, and a relative afferent pupillary defect . The disc is normal in retrobulbar cases — the classic phrase is that the patient sees nothing and the doctor sees nothing.

Significance: optic neuritis is frequently the presenting event of multiple sclerosis , and MRI of the brain with contrast stratifies subsequent risk based on the number of demyelinating lesions.

Treatment: intravenous methylprednisolone hastens recovery but does not change final visual outcome. Oral prednisone alone at conventional doses is avoided , as it was associated with an increased recurrence rate. Most patients recover useful vision.

Atypical features — bilateral simultaneous involvement, severe or poorly recovering vision loss, or marked disc swelling — should raise neuromyelitis optica spectrum disorder (aquaporin-4 antibody) or MOG antibody disease , both of which are treated differently from multiple sclerosis.

Other optic neuropathies

Non-arteritic anterior ischemic optic neuropathy — sudden painless monocular vision loss on waking, an altitudinal field defect, and a crowded optic disc in the fellow eye. Associated with hypertension, diabetes, sleep apnea and nocturnal hypotension.

Arteritic anterior ischemic optic neuropathy — from giant cell arteritis . Older patient, markedly elevated inflammatory markers, jaw claudication, scalp tenderness, and often preceding transient visual loss. Start high-dose corticosteroids immediately ; the fellow eye is at imminent risk, and biopsy remains informative for up to two weeks.

Toxic and nutritional optic neuropathy — ethambutol (a heavily tested cause, producing loss of color discrimination), methanol, B12 deficiency.

5. Papilledema and Idiopathic Intracranial Hypertension

Papilledema means disc swelling caused by raised intracranial pressure and is bilateral by definition. Distinguish it from other causes of a swollen disc:

• Papilledema Optic neuritis / AION
• Laterality Bilateral Usually unilateral
• Visual acuity Preserved until late Reduced early
• Afferent pupillary defect Usually absent Present
• Visual field Enlarged blind spot Central scotoma or altitudinal defect

Symptoms Headache, transient visual obscurations , pulsatile tinnitus, diplopia from sixth nerve palsy Eye pain or painless loss

Idiopathic intracranial hypertension (an enumerated blueprint topic) classically affects young women with obesity , presenting with headache, papilledema, transient visual obscurations, pulsatile tinnitus and sixth nerve palsy.

Diagnostic sequence, in order:

• Neuroimaging first (MRI with venography) to exclude a mass and cerebral venous sinus thrombosis
• Lumbar puncture showing elevated opening pressure with normal cerebrospinal fluid composition

Do not reverse that order — lumbar puncture before imaging risks herniation if a mass is present.

Precipitants to ask about: vitamin A and retinoids (isotretinoin) , tetracyclines , growth hormone, and withdrawal of corticosteroids.

Treatment: weight reduction, acetazolamide , and — for fulminant vision loss — optic nerve sheath fenestration or shunting. Vision, not headache, is what is being protected , so formal perimetry guides urgency.

6. Vestibular Neuronitis and Acute Vertigo

Enumerated under cranial neuropathy as vestibular neuronitis (acute labyrinthitis) .

Acute persistent vertigo lasting days with nausea, gait instability and horizontal nystagmus that beats away from the affected ear , without hearing loss (labyrinthitis adds hearing loss). The essential task is excluding a posterior circulation stroke , since a cerebellar infarct can present identically.

The HINTS examination — Head Impulse, Nystagmus type, Test of Skew — is more sensitive than early MRI for stroke in acute vestibular syndrome. Findings that indicate a central cause are a normal head impulse test , direction-changing nystagmus , or skew deviation . A normal head impulse test in a patient with severe ongoing vertigo is a danger sign, not a reassuring one.

Additional red flags: inability to walk unaided, severe headache or neck pain, and any other focal neurologic finding. Treatment of vestibular neuronitis is short-course vestibular suppressants followed promptly by vestibular rehabilitation , since prolonged suppressant use impairs central compensation.